Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraventricular tPA for Aneurysmal Subarachnoid Hemorrhage
NCT01878136Phase 2Withdrawn
- Sponsor
- Rush University Medical Center
- Start
- Mar 2015
- Primary completion
- Sep 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Rush University Medical Center. Planned start Mar 2015; status: withdrawn.
02
Drugs
tissue-plasminogen activator
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT01878136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878136.